RPTX - Repare Therapeutics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RPTX (1808158)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
13 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2024-03-28
RPTXSegal Lloyd MitchellPres, CEOS - Sale$4.62-5,141210,236-2%-$23,776
M
2024-03-28
RPTXForte SteveEVP, CFOS - Sale$4.62-1,61444,775-3%-$7,449
M
2024-03-28
RPTXZinda MichaelEVP, CHIEF SCIENTIFIC OFFICERS - Sale$4.65-86071,908-1%-$3,999
M
2024-03-28
RPTXKoehler MariaEVP, CHIEF MEDICAL OFFICERS - Sale$4.65-800231,4090%-$3,718
M
2024-03-25
RPTXForte SteveEVP, CFOS - Sale$4.67-2,47542,212-6%-$11,558
M
2024-03-25
RPTXZinda MichaelEVP, CHIEF SCIENTIFIC OFFICERS - Sale$4.67-1,35072,768-2%-$6,305
M
2024-03-25
RPTXKoehler MariaEVP, CHIEF MEDICAL OFFICERS - Sale$4.67-1,500232,209-1%-$7,000
M
2024-03-25
RPTXSegal Lloyd MitchellPres, CEOS - Sale$4.69-7,950208,543-4%-$37,259
M
2023-11-15
RPTXBvf Partners L P/il10%P - Purchase$5.09+1,227,301548,938-181%+$6,249,889
2023-11-02
RPTXBvf Partners L P/il10%P - Purchase$3.60+783,709485,083-262%+$2,821,352
M
2023-06-07
RPTXZinda MichaelEVP, Chief Scientific OfficerS - Sale$12.03-9,27360,118-13%-$111,526
2023-06-06
RPTXZinda MichaelEVP, Chief Scientific OfficerS - Sale$12.04-1,20069,391-2%-$14,448
2022-12-09
RPTXJerel DavisDirS - Sale$16.00-250,0003,315,739-7%-$4,000,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top